Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
21.90
-0.40 (-1.79%)
Jun 6, 2025, 9:44 AM CET

Celon Pharma Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
190.39176.62164.39161.92169.56135.48
Upgrade
Other Revenue
24.7128.3749.5331.9726.5321.97
Upgrade
Revenue
215.11204.98213.92193.89196.09157.45
Upgrade
Revenue Growth (YoY)
2.78%-4.18%10.33%-1.12%24.54%53.99%
Upgrade
Cost of Revenue
69.3863.1766.8266.4661.7236.64
Upgrade
Gross Profit
145.73141.81147.1127.42134.37120.81
Upgrade
Selling, General & Admin
123.86120.04111.12107.790.1183.44
Upgrade
Other Operating Expenses
21.9521.4114.3213.5213.56.93
Upgrade
Operating Expenses
199.65194.75175.46165.32144.96124.91
Upgrade
Operating Income
-53.92-52.94-28.35-37.9-10.59-4.1
Upgrade
Interest Expense
-2.34-2.47-2.66-1.67-1.55-0.67
Upgrade
Interest & Investment Income
0.30.160.371.850.080.14
Upgrade
Earnings From Equity Investments
-9.7-5.55----
Upgrade
Currency Exchange Gain (Loss)
-0.19-0.40.03-0.4-2.59-0.64
Upgrade
Other Non Operating Income (Expenses)
2.885.79.531.11-0.57-0.75
Upgrade
EBT Excluding Unusual Items
-62.97-55.49-21.08-37.01-15.22-6.02
Upgrade
Gain (Loss) on Sale of Investments
-2.28-----
Upgrade
Gain (Loss) on Sale of Assets
0.780.681.110.560.130.43
Upgrade
Asset Writedown
15.4515.45----
Upgrade
Pretax Income
-49.02-39.37-19.97-36.45-15.09-5.59
Upgrade
Income Tax Expense
-5.16-4.928.162.83-3.48-4.67
Upgrade
Net Income
-43.86-34.45-28.12-39.28-11.61-0.92
Upgrade
Net Income to Common
-43.86-34.45-28.12-39.28-11.61-0.92
Upgrade
Shares Outstanding (Basic)
535351514745
Upgrade
Shares Outstanding (Diluted)
535351514745
Upgrade
Shares Change (YoY)
4.01%2.86%0.04%9.32%3.74%-
Upgrade
EPS (Basic)
-0.83-0.66-0.55-0.77-0.25-0.02
Upgrade
EPS (Diluted)
-0.83-0.66-0.55-0.77-0.25-0.02
Upgrade
Free Cash Flow
-43.15-34.13-41.13-38.612.6-27.74
Upgrade
Free Cash Flow Per Share
-0.81-0.65-0.81-0.760.06-0.62
Upgrade
Dividend Per Share
--0.0800.0900.2900.070
Upgrade
Dividend Growth
---11.11%-68.97%314.29%-12.50%
Upgrade
Gross Margin
67.75%69.18%68.77%65.72%68.53%76.73%
Upgrade
Operating Margin
-25.07%-25.82%-13.25%-19.55%-5.40%-2.60%
Upgrade
Profit Margin
-20.39%-16.80%-13.15%-20.26%-5.92%-0.58%
Upgrade
Free Cash Flow Margin
-20.06%-16.65%-19.23%-19.91%1.33%-17.62%
Upgrade
EBITDA
-19.09-14.978.63-2.5727.8425.49
Upgrade
EBITDA Margin
-8.88%-7.31%4.04%-1.33%14.20%16.19%
Upgrade
D&A For EBITDA
34.8337.9636.9935.3338.4329.59
Upgrade
EBIT
-53.92-52.94-28.35-37.9-10.59-4.1
Upgrade
EBIT Margin
-25.07%-25.82%-13.25%-19.55%-5.40%-2.60%
Upgrade
Revenue as Reported
216.19207.19216.57194.59199.11159.99
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.